Join us for a conversation with Daniel S. Chen, MD, PhD, one of the leading voices in cancer immunotherapy. As the former Global Head of Cancer Immunotherapy Development at Genentech/Roche and current CEO of Synthetic Design Lab, Daniel shares lessons from developing groundbreaking therapies and his perspective on the future of oncology and clinical innovation.
#CancerImmunotherapy #Oncology #Biotech #ClinicalTrials #GlobalTrialAccelerators
RSS Feed